Author: United States. Secretary's Review Committee of the Task Force on Prescription Drugs
Publisher:
ISBN:
Category : Insurance, Pharmaceutical services
Languages : en
Pages : 180
Book Description
Report of the Secretary's Review Committee of the Task Force on Prescription Drugs
Author: United States. Secretary's Review Committee of the Task Force on Prescription Drugs
Publisher:
ISBN:
Category : Insurance, Pharmaceutical services
Languages : en
Pages : 180
Book Description
Publisher:
ISBN:
Category : Insurance, Pharmaceutical services
Languages : en
Pages : 180
Book Description
Report of the Secretary's Review Committee of the Task Force on Prescription Drugs
Author: United States. Task Force on Prescription Drugs. Secretary's Review Committee
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages :
Book Description
Report discusses issues concerning establishment of a prescription drug benefit for Medicare.
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages :
Book Description
Report discusses issues concerning establishment of a prescription drug benefit for Medicare.
Prescription Drugs Under Medicare
Author: Mickey C. Smith
Publisher: CRC Press
ISBN: 9780789013071
Category : Medical
Languages : en
Pages : 292
Book Description
How will the failures and findings of the past affect this fiercely debated current issue? In the near future, Congress may call for federal provision of outpatient prescription drugs as a benefit of the Medicare program. Prescription Drugs Under Medicare: The Legacy of the Task Force on Prescription Drugs is the story of the very first serious federal effort to study the feasibility of funding a drug benefits program for the elderly. That effort failed, and this fascinating text reveals why and how the program came to grief. Prescription Drugs Under Medicare explains the politics and practicalities of several government efforts to fund prescriptions for the elderly. The 1969 task force report is reprinted here in its entirety, along with comments from two of its primary architects, Dr. T. Donald Rucker and Dr. Philip Lee. Also included are excerpts from the report's review by the Dunlop Committee. The drug prices have changed, but the basic dilemma is the same. Prescription Drugs Under Medicare examines the burning issues, including: the reasons for the explosive growth in prescription prices from the 1950s onward the ongoing conflicts between the pharmaceutical industry and the government regulators the short-lived Reagan reforms of Medicare benefits the impact of managed care on the pharmaceutical marketplace Including powerful behind-the-scenes accounts, Prescription Drugs Under Medicare provides hard-to-find information and lucid analyses of this hotly debated subject. Pharmaceutical executives, medical economists, and policymakers will be fascinated by the story of how the stage was set for the congressional debates occurring in 2001.
Publisher: CRC Press
ISBN: 9780789013071
Category : Medical
Languages : en
Pages : 292
Book Description
How will the failures and findings of the past affect this fiercely debated current issue? In the near future, Congress may call for federal provision of outpatient prescription drugs as a benefit of the Medicare program. Prescription Drugs Under Medicare: The Legacy of the Task Force on Prescription Drugs is the story of the very first serious federal effort to study the feasibility of funding a drug benefits program for the elderly. That effort failed, and this fascinating text reveals why and how the program came to grief. Prescription Drugs Under Medicare explains the politics and practicalities of several government efforts to fund prescriptions for the elderly. The 1969 task force report is reprinted here in its entirety, along with comments from two of its primary architects, Dr. T. Donald Rucker and Dr. Philip Lee. Also included are excerpts from the report's review by the Dunlop Committee. The drug prices have changed, but the basic dilemma is the same. Prescription Drugs Under Medicare examines the burning issues, including: the reasons for the explosive growth in prescription prices from the 1950s onward the ongoing conflicts between the pharmaceutical industry and the government regulators the short-lived Reagan reforms of Medicare benefits the impact of managed care on the pharmaceutical marketplace Including powerful behind-the-scenes accounts, Prescription Drugs Under Medicare provides hard-to-find information and lucid analyses of this hotly debated subject. Pharmaceutical executives, medical economists, and policymakers will be fascinated by the story of how the stage was set for the congressional debates occurring in 2001.
Developments in Aging
Author: United States. Congress. Senate. Special Committee on Aging
Publisher:
ISBN:
Category : Older people
Languages : en
Pages : 526
Book Description
Publisher:
ISBN:
Category : Older people
Languages : en
Pages : 526
Book Description
Clearinghouse Review
Author:
Publisher:
ISBN:
Category : Consumer protection
Languages : en
Pages : 1034
Book Description
Publisher:
ISBN:
Category : Consumer protection
Languages : en
Pages : 1034
Book Description
National Library of Medicine Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1008
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1008
Book Description
First multi-year cumulation covers six years: 1965-70.
Drug Bioequivalence, a Report of the ...Drug Bioequivalence Study Panel
Author: United States. Technology Assessment Office
Publisher:
ISBN:
Category :
Languages : en
Pages : 92
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 92
Book Description
Hearings, Reports and Prints of the Senate Committee on Labor and Public Welfare
Author: United States. Congress. Senate. Committee on Labor and Public Welfare
Publisher:
ISBN:
Category : Labor policy
Languages : en
Pages : 1252
Book Description
Publisher:
ISBN:
Category : Labor policy
Languages : en
Pages : 1252
Book Description
Review Panel on New Drug Regulation
Author: United States. Department of Health, Education, and Welfare. Review Panel on New Drug Regulation
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 214
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 214
Book Description
Prescription Drug Labeling and Price Advertising
Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance
Publisher:
ISBN:
Category : Advertising
Languages : en
Pages : 420
Book Description
Publisher:
ISBN:
Category : Advertising
Languages : en
Pages : 420
Book Description